Learning Objectives:

1. Describe the subtypes of clinical Myasthenia Gravis

2. Define indications for ordering various Myasthenia antibodies

3. Articulate the risks and benefits of old and new Myasthenia Gravis treatments

Session date: 
12/15/2023 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Megan Shanks, MD